A B STRA CT Intraluminal manometric studies were carried out in 19 patients with untreated achalasia and in 20 normals. Lower esophageal sphincter (LES) pressure was 50.5 ±4.6 mm Hg in patients with achalasia as compared with 19.4 ±1.3 mm Hg in the normal group.
INTRODUCTION
In patients with achalasia, dysfunction of the lower esophageal sphincter (LES)' plays a major role in the pathogenesis of impaired esophageal emptying. Although this point is well recognized, a clear understanding of the pathophysiology of this dysfunction is not available. The classic concept of a normotensive LES, which fails to relax upon deglutition (1, 2) has been questioned (3) . It has been suggested that LES dysfunction consisted of a marked elevation in LES pressure and a limited, but distinct, ability to relax upon deglutition. By this latter concept, LES hypertension would play a major role in the impairment of esophageal emptying. It is the purpose of this study to utilize a method of proven A portion of this work was presented before the plenary session of the American Federation for Clinical Research, Midwestern Section, Chicago, Ill. 5 November 1970.
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validity (4) (5) (6) to quantitate LES pressure in patients v, iih achalasia, and to define the role of gastrin in the p-thogenesis of LES hypertension.
METHODS Three water-filled polyvinyl catheters, 1.4 mm internal diameter, were used to transmit intraluminal pressures to external transducers (Statham P23BB). Output from these transducers was recorded on a multichannel Beckman curvilinear ink-writing recorder. The recording catheters were arranged to measure intraluminal pressure at three points, 5 cm apart, through side openings 1.2 mm in diameter. Gastric infusion was done through a fourth catheter which had multiple perforations over the 8 cm distal segment. Serum' gastrin determinations were performed by the radioimmunoassay technique described by McGuigan (7-9). . In patients with achalasia, gastric acidification lowered pressure from 50.5 ±4.6 mm Hg to 7.7 ±0.7 mm Hg, a decrease of 86.9 ±2.2%. The nadir of pressure during gastric acidification was similar in normals and patients with achalasia (P > 0.05). The per cent reduction in pressure was significantly different (P < 0.001).
To ascertain whether the high, acid-suppressible levels of LES pressure in patients with achalasia were due to increased levels of endogenous gastrin, serum gastrin levels were obtained on all patients in both groups. These results in Fig. 3 show no statistical difference between the two groups of patients (P > 0.05). In each group, normals and patients with achalasia, the LES pressure and serum gastrin level did not correlate (P > 0.05).
Since LES hypertension in achalasia was not related to elevated endogenous levels of gastrin, the possibility of an increased sensitivity to gastrin was evaluated. In Fig. 4 , dose-response curves of the LES to intravenous injections of synthetic gastrin I are shown. The peak LES response, averaged over a 1 min period, was expressed as a per cent of the initial base line LES pressure. Qualitative LES response was identical in both groups. The response began within 1 min, peaked at 3 min, and dissipated to normal levels within 10 min. Quantitatively, however, the response of the two groups was different. The dose-response curve in the patients with achalasia was shifted to the left, which indicates greater sensitivity to exogenous gastrin I. The threshold dose was lower in patients with achalasia. The steeply sloped linear portion of the dose-response curve, although shifted to the left, remained parallel to the comparable linear portion of the curve in the normal group. The peak response of the LES in patients with acha- To ascertain whether the hypertensive initial LES pressure in patients with achalasia was responsible for the increased sensitivity to gastrin I, studies were repeated in patients with achalasia who had undergone a clinically and radiographically successful pneumatic dila-DISCUSSION These studies indicate that the LES in patients with achalasia, is (a) hypertensive, (b) suppressed by gastric acidification, and (c) supersensitive to exogenous gastrin I. We propose that LES hypertension in patients with achalasia is due to supersensitivity to endogenous gastrin.
Cohen, using a constantly perfused recording system, has shown that LES pressure in patients with untreated achalasia is twice that of normal subjects (3, 11) . His findings, confirmed in this study, differ from the normotensive levels of LES pressure previously reported (1, 2) . This discrepancy was found to be the result of the methods employed in quantitating LES pressure. Prior studies were performed with uninfused open-tipped catheters, a method shown to be inadequate for recording the entire range of gastrointestinal sphincter pressure (4, 5) . Harris and Pope have demonstrated that pressures recorded by this technique were influenced by mucosa sealing the recording orifice (12) . This produced significant artifacts in interpreting LES pressure. The simple modification of measuring LES pressure with a constantly perfused recording system, has provided an accurate valid interpretation of the full range of LES strength (4) (5) (6) .
Although the LES in patients with achalasia is hypertensive, gastric acidification consistently reduced the pressure as found in normals. This response of the LES was interpreted as a specific response to a reduction in endogenous gastrin released from the stomach. This interpretation was based on direct and indirect quantitation of the effect of gastric acidification on the release of gastrin in man (13) and animal models (14, 15) . Dose-response curves of per cent change in LES pressure against log dose of gastrin I in 13 normals, 11 patients with untreated achalasia, and 7 patients after pneumatic dilatation (Fig. 5) . Patients with achalasia having a normal LES pressure after treatment, still show supersensitivity to gastrin I. ference in response. A greater absolute and a greater per cent reduction in pressure was found in the achalasic group. The nadir of pressure attained during inhibition was the same in the two groups. This finding suggested that a greater portion of the LES pressure in patients with achalasia was determined by endogenous gastrin. The portion of LES pressure that was not acid suppressible and, therefore, not gastrin dependent, did not differ in the two groups. This large, gastrin-related portion of LES pressure in patients with achalasia suggested two possibilities: (a) either endogenous levels of gastrin were increased, or (b) the LES was supersensitive to endogenous gastrin. The first possibility was proven incorrect by demonstrating that patients with achalasia had normal levels of serum gastrin. This possibility initially seemed unlikely since patients with elevated levels of gastrin, as in pernicious anemia (16) (17, 18) and Trendelenburg (19) , who demonstrated these findings with experimentally denervated animal models.
Although the maximum per cent increase in LES pressure was similar in both groups, patients with achalasia had a greater absolute increase in LES pressure. This finding was related to the greater initial LES pressure in achalasia. Expression of data as a per cent of initial pressure normalizes for baseline values and allows for quantitation of dose-response relationships. When the LES pressure of a normal was elevated to the achalasic range, the maximum absolute change in pressure was similar to that of the patient with achalasia. Similarly, when the LES pressure in patients with achalasia was reduced to a normal level by pneumatic dilatation, the dose-response curve was still shifted to the left, but now the absolute LES response was similar to that obtained in normals.
Further examination of the dose-response curves revealed another possible manifestation of supersensitivity. At points beyond the maximal response, autoinhibition or the diminished response of a system to doses beyond that which yielded a maximum response, was observed. It is due to saturation of all high affinity excitatory receptors with additional molecules combining with a low affinity inhibitory receptor (20) . Whereas this phenomenon, was observed in both groups, it occurred at lower doses and to a more marked degree in patients with achalasia. This may result from supersensitivity of inhitory as well as excitatory receptors.
Denervation supersensitivity of the body of the esophagus has been generally accepted as a clinical criteria for the diagnosis of achalasia (21) . However, the LES has not been studied for this property. Anatomic evidence of denervation has been shown in the sphincter zone (22) , but this loss of myenteric ganglia has not been consistently observed (23, 24) . Although conclusive evidence demonstrating denervation of the achalasic LES is not available, this study does establish supersensitivity to gastrin I. We propose that this supersensitivity is due to denervation. There are several mechanisms by which the achalasic LES could become supersensitized to gastrin. Cannon has shown that denervation leads to supersensitivity not only to natural neural transmitters, but also, nonspecifically, to other chemical stimulants (18) . Gastrin supersensitivity may, therefore, be a nonspecific reaction of a denervated structure. A second possible mechanism of gastrin supersensitivity involves an intermediate site of action of gastrin in the control of LES strength. It has been shown that gastrin effect on smooth muscle is through postganglionic release of acetylcholine (25) . Studies on the circular smooth muscle of the opossum LES in vitro confirm this mechanism of action.7 Therefore, supersensitivity may be due to the neural transmitter, acetylcholine, not directly to the peptide hormone. Regardless of the specific mechanism of gastrin supersensitivity, the significance of this finding is not altered. In achalasia, the marked acid suppression of the elevated LES pressure is due to inhibition of endogenous gastrin release. Therefore, it is suggested that the elevated LES pressure is due to supersensitivity to endogenous gastrin.
The demonstration of lower esophageal sphincter hypertension and an elucidation of its pathophysiology are initial steps in searching for a medical program for treating achalasia. If the sphincter can partially relax, as shown by Cohen (3) and confirmed by us, then the sphincter-to-stomach gradient is dependent upon both the level of sphincter pressure from which the relaxation occurs and the degree of sphincter relaxation. The correlation between clinical improvement and reduction in sphincter pressure indicates that if LES pressure were lowered through inhibition of gastrin effect, then achalasia might be treated medically.
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